Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis.
Mohitosh BiswasSumaiya Khatun KaliAshish Kumar SarkerChonlaphat SukasemPublished in: Expert opinion on drug safety (2023)
genetic polymorphism has no significant impact on the risk of MACEs or bleeding events in patients treated with clopidogrel.